Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ — Stella

Recruiting

Back to Minor Ischemic Stroke trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Beijing Tiantan Hospital, Beijing, Beijing Municipality

Key details

Phase

Large-scale testing

Sponsor

Beijing Tiantan Hospital

Enrollment target

~1,386 participants

Started

July 2025

Primary completion

July 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov